Publication | Closed Access
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
63
Citations
35
References
2020
Year
FibrosisAntifibrotic TherapyInflammatory Lung DiseaseIdiopathic Pulmonary FibrosisImmunologyPathologyPulmonary PharmacologyPulmonary FibrosisHeterodimer S100a8/a9Pulmonary MedicineMedicinePotent Therapeutic TargetPulmonary Disease
| Year | Citations | |
|---|---|---|
Page 1
Page 1